Reference systems for kinase drug discovery: chemical genetic approaches to cell-based assays

J Andrew Whitney1

  • 1Department of Research Informatics, Cellular Genomics, Inc., Branford, CT, USA. andyw@cellulargenomics.com

Insights

Protein kinases are crucial in diseases like cancer. This review covers methods for developing cell-based assays to find selective kinase inhibitors, essential for new drug discovery.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Protein kinases are vital in cellular signaling pathways.
  • Dysregulated kinase activity is implicated in major diseases such as cancer, inflammation, and diabetes.
  • The large number of kinases (~518) and their role as drug targets necessitate effective inhibitor development.

Purpose of the Study:

  • To review methods for developing cell-based assays for identifying kinase inhibitors.
  • To discuss the advantages and disadvantages of various assay approaches.
  • To introduce chemical genetic methods for assay establishment and functional selectivity profiling.

Main Methods:

  • Description of various cell-based assay development strategies.
  • Comparative analysis of different assay methodologies.
  • Application of chemical genetics for assay validation and inhibitor profiling.

Main Results:

  • Outlines established and emerging techniques for kinase inhibitor screening.
  • Provides a critical evaluation of current cell-based assay approaches.
  • Highlights the utility of chemical genetics in assessing inhibitor selectivity and function.

Conclusions:

  • Effective cell-based assays are critical for discovering potent and selective kinase inhibitors.
  • Chemical genetic methods offer valuable tools for assay development and functional profiling.
  • Advancements in assay technology are crucial for targeting kinases in disease treatment.

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...